A prospective double blind randomized clinical trial was performed in Imam Reza teaching hospital in Tabriz-Iran. Ninety patients presenting to ED with Migraine headache were enrolled in two equal groups (I,II). In group I, we used intravenous propofol (10-20 mg every 3 -5 minutes) slowly and in group II, we used dexamethasone (approximately 0.15 mg/kg) slowly. Our inclusion criteria were as follows:
A. At least five attacks fulfilling the criteria in B, C, D, and E.
B. Attack lasts 4 to 72 hours with or without treatment.
C. Headache has at least two of the following characteristics:
1. Unilateral location
2. Pulsating quality
3. Moderate to severe intensity
4. Aggravated by walking up stairs or similar routine
physical activity
D. During headache, at least one of the following:
1. Nausea or vomiting (or both)
2. Photophobia and phonophobia
E. History, physical. and neurologic examination and, if
appropriate, diagnostic tests to exclude related organic disease.
Our exclusion criteria were as follows:
1-Patients who received narcotic, triptans or other vasoconstrictors like intravenous dihydroergotamine
2- Allergy to eggs or soya
Pain explained by patients, based on VAS (Visual Analogue Scale) was recorded at the time of entrance to Emergency medicine Department, and in 5, 10, 20,30 and 45 minutes after injection.